Abstract: A driver support system includes a processor that acquires a heart rate of a target person; evaluates a health condition of the target person based on the heart rate of the target person; and performs an operation setting of a moving object into which the target person gets as a driver. The processor evaluates the health condition of the target person based on an ordinary heart rate, which is a heart rate of the target person during an ordinary period, and a pre-driving heart rate which is a heart rate of the target person when the target person arrives at the moving object, performs the operation setting of the moving object based on a result of the health condition of the target person evaluated when the target person gets into the moving object as a driver.

Abstract: Provided is a health evaluation system that includes: an acquisition unit that acquires a blood pressure value of a target person; and an evaluation unit that evaluates a health condition of the target person based on the acquired blood pressure value. The evaluation unit evaluates the health condition of the target person based on: a standing-state blood pressure value that is a blood pressure value measured when the target person is heading toward a moving body in a standing state; and a seated-state blood pressure value that is a blood pressure value of the target person measured after boarding the moving body and seated on a seat.

Abstract: A health assessment system includes a processor that acquires biometric measurement data measured by a wearable terminal worn by a target person, the biometric measurement data being biometric data of the target person; generates complementary biometric data for complementing the biometric measurement data in a missing period in which the acquisition unit is not able to acquire the biometric measurement data from the wearable terminal; and assesses a health condition of the target person based on the biometric measurement data and the complementary biometric data, the processor acquires exercise information, which is information about exercise of the target person, from a mobile terminal carried by the target person, generates the complementary biometric data in the missing period, based on the exercise information of the target person which is obtained from the mobile terminal.

Abstract: A driver support system includes: an acquisition unit that acquires biometric data of a driver of a moving object; an evaluation unit that evaluates a health condition of the driver; and an interactive response unit that executes an interaction operation for interactive response with the driver using an HMI device mounted on the moving object, the evaluation unit being configured to; when estimating based on the biometric data for the driver that the health condition of the driver is poor, instruct the interactive response unit to execute the interaction operation, thereby acquiring a response input, which is a response of the driver to a response facilitating output that facilitates the driver to respond in the interaction operation; and determine the health condition of the driver based on a degree of suitability of the response input to the response facilitating output.

Abstract: A navigation system includes an evaluation unit for evaluating a degree of a health state quality for a driver of a moving body, and a route guidance unit for searching a route from a current position of the moving body to a destination, and for performing guidance of the searched route, the route guidance unit determines a search condition of a route to the destination based on an evaluation result of a health state of the driver in the evaluation unit.

Abstract: A component concentration measuring device includes a liquid collecting unit configured to collect a main liquid including a measurement target component which is an object to be measured and discharge a mixed liquid obtained by mixing the main liquid with an auxiliary liquid supplied from an outside; and a first sensing unit including a first flow path positioned downstream of the liquid collecting unit and an in-mixed-liquid concentration measuring unit positioned in the first flow path and configured to measure a first measurement target component concentration which is the concentration of the measurement target component in the mixed liquid.

Abstract: To provide a base sequence for protein expression that can increase the yield of protein such as diastatic enzyme by further activating a promoter of a particular gene. A base sequence 1 for protein expression includes: a gene 3 encoding protein 2; a promoter 4 of the gene 3, the promoter being linked upstream of the gene 3; and a cis element 5 whose activity is improved by an artificial transcription factor 6, the cis element being linked further upstream of the promoter 4. The cis element 5 is represented by SEQ ID NO: 1.

Abstract: To provide a base sequence for protein expression that can increase the yield of protein such as diastatic enzyme by further activating a promoter of a particular gene. A base sequence 1 for protein expression includes: a gene 3 encoding protein 2; a promoter 4 of the gene 3, the promoter being linked upstream of the gene 3; and a cis element 5 whose activity is improved by an artificial transcription factor 6, the cis element being linked further upstream of the promoter 4. The cis element 5 is represented by SEQ ID NO: 1.

Abstract: To provide a base sequence for protein expression that can increase the yield of protein such as diastatic enzyme by further activating a promoter of a particular gene. A base sequence 1 for protein expression includes: a gene 3 encoding protein 2; a promoter 4 of the gene 3, the promoter being linked upstream of the gene 3; and a cis element 5 whose activity is improved by an artificial transcription factor 6, the cis element being linked further upstream of the promoter 4. The cis element 5 is represented by SEQ ID NO: 1.

Abstract: To provide a base sequence for protein expression that can increase the yield of protein such as diastatic enzyme by further activating a promoter of a particular gene. A base sequence 1 for protein expression includes: a gene 3 encoding protein 2; a promoter 4 of the gene 3, the promoter being linked upstream of the gene 3; and a cis element 5 whose activity is improved by an artificial transcription factor 6, the cis element being linked further upstream of the promoter 4. The cis element 5 is represented by SEQ ID NO: 1.

Abstract: To provide a base sequence for protein expression that can increase the yield of protein such as diastatic enzyme by further activating a promoter of a particular gene. A base sequence 1 for protein expression includes: a gene 3 encoding protein 2; a promoter 4 of the gene 3, the promoter being linked upstream of the gene 3; and a cis element 5 whose activity is improved by an artificial transcription factor 6, the cis element being linked further upstream of the promoter 4. The cis element 5 is represented by SEQ ID NO: 1.

Abstract: To provide a base sequence for protein expression that can increase the yield of protein such as diastatic enzyme by further activating a promoter of a particular gene. A base sequence 1 for protein expression includes: a gene 3 encoding protein 2; a promoter 4 of the gene 3, the promoter being linked upstream of the gene 3; and a cis element 5 whose activity is improved by an artificial transcription factor 6, the cis element being linked further upstream of the promoter 4. The cis element 5 is represented by SEQ ID NO: 1.

Abstract: An Aspergillus mutant strain characterized in that it is an auxotrophic mutant strain of Aspergillus oryzae strain AOK27L.

Abstract: An object of the invention is to provide cellobiohydrolase with high activity. The activity of cellobiohydrolase can be improved by substituting, with alanine, asparagine that is the amino acid at position 62 from the N-terminal of cellobiohydrolase shown in SEQ ID NO: 1, or asparagine at a position corresponding to the position 62 in an amino acid sequence corresponding to the sequence of the cellobiohydrolase shown in SEQ ID NO: 1.

Abstract: A saccharifying enzyme composition, by which excellent saccharification performance can be attained even with a low usage thereof, as well as a method for producing a saccharified solution using the same are provided. The saccharifying enzyme composition subjects lignocellulose-based biomass as a substrate to a saccharification treatment. The saccharifying enzyme composition comprises an endoglucanase not containing a cellulose-binding domain, a cellobiohydrolase containing a cellulose-binding domain, and a ?-glucosidase containing a cellulose-binding domain.

Abstract: Provided are an Aspergillus mutant strain which can dramatically enhance production of a heterologous enzyme when a saccharifying enzyme gene is transferred into the strain to perform transformation and a transformant having a saccharifying enzyme gene transferred into the Aspergillus mutant strain. The Aspergillus mutant strain has been completely or partially deficient in three genes of Aspergillus oryzae strain HO2 (accession number: NITE BP-01750): a prtR gene coding for a transcription factor; a pepA gene coding for an extracellular acid protease; and a cpI gene coding for an extracellular acid carboxypeptidase.

Abstract: Provided are an Aspergillus mutant strain which can dramatically enhance production of a heterologous enzyme when a saccharifying enzyme gene is transferred into the strain to perform transformation and a transformant having a saccharifying enzyme gene transferred into the Aspergillus mutant strain. The Aspergillus mutant strain has been completely or partially deficient in three genes of Aspergillus oryzae strain HO2 (accession number: NITE BP-01750): a prtR gene coding for a transcription factor; a pepA gene coding for an extracellular acid protease; and a cpI gene coding for an extracellular acid carboxypeptidase.

Abstract: An object of the invention is to provide cellobiohydrolase with high activity. The activity of cellobiohydrolase can be improved by substituting, with alanine, asparagine that is the amino acid at position 62 from the N-terminal of cellobiohydrolase shown in SEQ ID NO: 1, or asparagine at a position corresponding to the position 62 in an amino acid sequence corresponding to the sequence of the cellobiohydrolase shown in SEQ ID NO: 1.

Abstract: The present invention relates to a polypeptide which has ?-glucosidase activity, and which includes an amino acid sequence represented by SEQ ID NO: 1, a polypeptide including an amino acid sequence in which one or several amino acids are deleted, substituted, or added in the amino acid sequence represented by SEQ ID NO: 1, or a polypeptide including an amino acid sequence having 91% or greater sequence identity with the amino acid sequence represented by SEQ ID NO: 1. According to the present invention, a novel ?-glucosidase enzyme derived from Acremonium cellulolyticus, a polynucleotide encoding the ?-glucosidase, an expression vector for expressing the ?-glucosidase, a transformant incorporated with that expression vector, and a method for producing a cellulose degradation product using the ?-glucosidase can be provided.

Abstract: The present invention relates to a polypeptide which has ?-glucosidase activity, and which includes an amino acid sequence represented by SEQ ID NO: 1, a polypeptide including an amino acid sequence in which one or several amino acids are deleted, substituted, or added in the amino acid sequence represented by SEQ ID NO: 1, or a polypeptide including an amino acid sequence having 90% or greater sequence identity with the amino acid sequence represented by SEQ ID NO: 1. According to the present invention, a novel ?-glucosidase enzyme derived from Acremonium cellulolyticus, a polynucleotide encoding the ?-glucosidase, an expression vector for expressing the ?-glucosidase, a transformant incorporated with that expression vector, and a method for producing a cellulose degradation product using the ?-glucosidase can be provided.